Ismael Matus, MD
Pulmonary Disease · Newark, DENPI 1538118070
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $19,790 of the $26,568 with a category attached, or 74.5%. Johnson & Johnson accounts for 77.2% of it on its own, with 13 other manufacturers making up the rest.
Across 72 payments — averaging $369.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$21K
- Intuitive Surgical$2K
- Noah Medical Corporation$2K
- Medical Device Business Services, Inc.$647
- Pinnacle Biologics, Inc$429
- Galvanize Therapeutics, Inc$380
- plus $597 from 8 others
What the payments were for
- Consulting fees$19,79074%
- Speaking & faculty fees$3001%
- Travel & lodging$4,53317%
- Food & beverage$1,9347%
- Education$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 15 | $20,523 |
| Intuitive Surgical | 11 | $2,235 |
| Noah Medical Corporation | 13 | $1,757 |
| Medical Device Business Services, Inc. | 6 | $647 |
| Pinnacle Biologics, Inc | 4 | $429 |
| Galvanize Therapeutics, Inc | 5 | $380 |
| Pulmonx Corporation | 6 | $166 |
| Boston Scientific | 2 | $165 |
| AstraZeneca | 3 | $70 |
| Covidien LP | 1 | $59 |
| Merck | 2 | $58 |
| Daiichi Sankyo Inc. | 2 | $41 |
| Caris MPI, Inc. | 1 | $26 |
| Olympus America Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MONARCH$13,391
- Monarch Platform$7,393
- Da Vinci Surgical System$2,084
- GALAXY$425
- Photofrin$300
- ALIYA SYSTEM$298
- GENERAL PULMONARY$107
How this compares
$26,568 in reported general payments places this provider in the 85th percentile of 39 pulmonary disease providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Newark
- Albert RizzoNewark$162K
- Haroon RajaNewark$44K
- Naveed HasanNewark$3K
- Theodora FynnNewark$2K
- Sam ThomasNewark$2K
- Irene SwiftNewark$2K
- Donald CollinsNewark$2K
- Sajjad AhmadNewark$749
- Sonali BishnoiNewark$686
- Farid MoosavyNewark$615
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.